AM
INDV icon

Anqa Management’s Indivior Pharmaceuticals INDV Stock Holding History

Anqa Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$17.5M Hold
805,446
– – 26.29% 1
2023
Q2 		$18.7M Buy
+805,446
New +$18.5M 20.79% 1

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $9.43B AUM 69.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Anqa Management's INDV Position: Q3 2023 in Review

Anqa Management held its Indivior Pharmaceuticals (INDV) position steady in Q3 2023 at 805,446 shares worth $17.5M. The position accounts for 26.29% of the portfolio, ranked #1.

Anqa Management first reported a position in INDV in Q2 2023 and has held it in 2 quarters since. The position peaked at $18.7M in Q2 2023. 76 funds tracked by Wall St. Rank hold INDV as of Q3 2023.

  • Anqa Management held 805,446 shares of Indivior Pharmaceuticals worth $17.5M as of Q3 2023.
  • Anqa Management left its Indivior Pharmaceuticals share count unchanged in Q3 2023.
  • Indivior Pharmaceuticals made up 26.29% of Anqa Management's portfolio in Q3 2023, its #1 holding.
  • Anqa Management first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 2 quarters since.
  • Anqa Management's Indivior Pharmaceuticals position peaked at $18.7M in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2023.

Based on Anqa Management's 13F filing for Q3 2023, filed 13 Nov 2023.